Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Vérane, Schwiertz"'
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
Autor:
Estelle Bourbon, Pierre Sesques, Morgane Gossez, Jérémie Tordo, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Guillaume Aussedat, Alizée Maarek, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Camille Golfier, Hélène Lequeu, Anne Lazareth, Vérane Schwiertz, Sébastien Viel, Maryam Idlhaj, Hervé Ghesquières, Guillaume Monneret, Emmanuel Bachy, Fabienne Venet
Publikováno v:
Blood Advances
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩
Despite their unprecedented success in relapsed/refractory (R/R) large B-cell lymphoma (LBCL), anti-CD19 CAR T cells are associated with significant toxicity, and more than half of patients relapse. As monocytes emerged as key players in CAR therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6334914490903dc8f9f76f2077aa2fa6
https://doi.org/10.1182/bloodadvances.2021006563
https://doi.org/10.1182/bloodadvances.2021006563
Autor:
Romain Varnier, Alicja Puszkiel, Michel Tod, Sara Calattini, Lea Payen, Jonathan Lopez, Jérome Guitton, Vérane Schwiertz, Juliette Fontaine, Julien Peron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Olivier Colomban, Diane Augu-Denechere, Gilles Freyer, Benoit You
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:361-373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34c3c8185da30f8bb4b569e8fb983b07
https://doi.org/10.1007/s00280-023-04508-9
https://doi.org/10.1007/s00280-023-04508-9
Autor:
Juliette Périchou, Florence Ranchon, Chloé Herledan, Laure Huot, Virginie Larbre, Isabelle Carpentier, Anne Lazareth, Lionel Karlin, Karen Beny, Nicolas Vantard, Vérane Schwiertz, Anne Gaelle Caffin, Amandine Baudouin, Pierre Sesques, Gabriel Brisou, Hervé Ghesquières, Gilles Salles, Catherine Rioufol
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243309 (2020)
Long-term multiple myeloma therapy by immunomodulatory drugs (IMiDs) raises the question of management of adverse effects. The aim of this study is to assess the impact of an educational session for patients on the acquisition of knowledge to manage
Externí odkaz:
https://doaj.org/article/1646970f41994e27bac5896366bc1d2a
Autor:
Clémentine Fronteau, Maxime Paré, Philippe Benoit, Sophie Tollec, Catherine Hamon, Vérane Schwiertz, Christian Maillard, Amélie Cransac, Christelle Volteau, Jean-François Huon, Véronique Burgeot, Martine Tching-Sin, Corinne Guérin, Laurent Flet
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220383 (2019)
This study aimed to assess patient investigational medication knowledge and to identify factors associated with medication understanding by adult outpatients included in clinical trials. A cross-sectional prospectively designed survey was conducted o
Externí odkaz:
https://doaj.org/article/103d6f79a73a4f38893ff4f493cd1ced
Autor:
Amélie Dubromel, Chloé Herledan, Pauline Pralong, Florence Ranchon, Nicolas Vantard, Virginie Larbre, Jean-François Nicolas, F. Hacard, Catherine Rioufol, Audrey Nosbaum, Frédéric Bérard, Amandine Baudouin, Anne-Gaëlle Caffin, Vérane Schwiertz
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1552-1559
Background Cancer patients are being exposed to antineoplastic drugs more frequently and for longer periods, resulting in a higher risk of hypersensitivity reactions. The aim of this study was to assess the pharmaceutical time and direct cost of drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e08ffc29f83e2cb592504576e8e7b9e
https://doi.org/10.1177/10781552211035695
https://doi.org/10.1177/10781552211035695
Autor:
Herve Ghesquieres, Gilles Salles, Amandine Baudouin, Chloé Herledan, Florence Ranchon, Vérane Schwiertz, Lionel Karlin, Catherine Rioufol
Publikováno v:
Hematological Oncology. 38:576-583
The rapid emergence of expensive anticancer therapies is leading to exponential growth in healthcare expenses. In clinical trials, most investigational drugs are provided free of charge by industrial and academic sponsors. This results in drug cost s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b73f74dba7b6802e60df4ddaee33a9
https://doi.org/10.1002/hon.2753
https://doi.org/10.1002/hon.2753
Autor:
Pierre Sujobert, Pierre Sesques, Doriane Cavalieri, Violaine Safar, Emmanuel Bachy, Fadhela Bouafia, Vérane Schwiertz, Jeremie Tordo, Olivier Hequet, Florence Ader, Gabriel Brisou, Fabienne Venet, Yazid Arkam, Lionel Karlin, Catherine Rioufol, Herve Ghesquieres, Frederic Peyrade, Helene Lequeu, Florent Wallet, Valérie Mialou, Adrien Chauchet, Alexandra Traverse Glehen, Anthony Dhomps, Marlène Vercasson, Anne Lazareth, Marion Choquet, Sébastien Viel, Dana Ghergus, Emmanuelle Nicolas-Virelizier, Gilles Salles, Carole Hospital-Gustem, Emmanuelle Ferrant, Camille Golfier, Silvana Novelli, Florence Ranchon, Perrine Devic
Publikováno v:
American journal of hematologyREFERENCES. 95(11)
Two autologous anti-CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel [axi-cel] and tisagenlecleucel [tisa-cel]) are commercially approved in Europe for relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). We performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f99cf3c88efac612c50fc01e60c43f8
https://pubmed.ncbi.nlm.nih.gov/32744738
https://pubmed.ncbi.nlm.nih.gov/32744738
Autor:
Florence Ranchon, Laura Sarfati, Vérane Schwiertz, Catherine Rioufol, Nicolas Vantard, Virginie Larbre, Amélie Faudel, Stéphanie Parat
Publikováno v:
Journal of Evaluation in Clinical Practice. 25:11-20
Rationale, aims and objectives In the past 2 decades, there has been an increasing interest in simulation-based learning programs to prevent medication error (ME). To improve knowledge, skills, and attitudes in prescribers, nurses, and pharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b462644cad12881de1c5f450d0e423
https://doi.org/10.1111/jep.12883
https://doi.org/10.1111/jep.12883
Autor:
Steven Le Gouill, Laure Huot, Pascale Guerre, Clémentine Fronteau, Vérane Schwiertz, Emilie Fargier, Arthur Dony, Violaine Safar, Stéphane Savouroux, Emmanuel Gyan, Jean-François Tournamille, Nicolas Vantard, Patrick Tomaré, Catherine Rioufol, Emmanuel Bachy, Florence Ranchon, Gilles Salles, Nathalie Hequet
Publikováno v:
Annals of Hematology. 97:123-131
Rituximab is used as a standard of care for follicular lymphoma and is usually administered intravenously. A novel subcutaneous formulation recently showed non-inferior efficacy with similar pharmacokinetic and safety profiles compared to intravenous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2051d05dc4b75c8730ce82e010fe07c
https://doi.org/10.1007/s00277-017-3147-y
https://doi.org/10.1007/s00277-017-3147-y
Autor:
Estelle Bourbon, Emilie Henin, Aurore Gouraud, Florence Ranchon, Clémentine Sarkozy, Amandine Baudouin, Nicolas Vantard, Fadhela Bouafia-Sauvy, Gilles Salles, Thierry Vial, Emmanuel Bachy, Lionel Karlin, Catherine Rioufol, Anne Gaelle Caffin, Vérane Schwiertz
Publikováno v:
Hematological Oncology. 36:399-406
The aim of this retrospective cohort study was to investigate the incidence of delayed methotrexate elimination in patients treated with high-dose methotrexate (≥1 g/m2 ) for haematological malignancy and to identify the impact of interacting drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8242798f1a059620a913813310f18094
https://doi.org/10.1002/hon.2479
https://doi.org/10.1002/hon.2479